Impel Pharmaceuticals Inc. (IMPL) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Impel Pharmaceuticals Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-0.68
Burn Risk
P/B Ratio
-1.99
Equity Deficit
Earnings Yield
-147.23%
Yield Gap
Profitability Health
2022Return on Equity
293.14%
Strong
WeakModerateStrong
Operating Margin
-657.48%
Weak
WeakModerateStrong
Net Profit Margin
-1023.08%
Weak
WeakModerateStrong
Growth Indicators
2022Revenue Growth
1794.01%
Strong
WeakModerateStrong
Net Income Growth
-69.12%
Weak
WeakModerateStrong
EPS Growth
-5.34%
Weak
WeakModerateStrong
Efficiency & Liquidity
2022Current Ratio
3.60
Strong
WeakModerateStrong
Quick Ratio
3.22
Strong
WeakModerateStrong
Asset Turnover
0.14x
Weak
WeakModerateStrong
Inventory Turnover
0.77x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-108.08%
Weak
WeakModerateStrong
EV / Free Cash Flow
-0.83x
Strong
WeakModerateStrong
Net Debt / EBITDA
0.10x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.278
Strong
WeakModerateStrong
Return on Invested Capital
-122.46%
Weak
WeakModerateStrong
Cash Conversion Cycle
345.97 days
Weak
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for IMPL.
View Financial Statements